EPM
SONM icon

Equitec Proprietary Markets’s DNA X Inc SONM Stock Holding History

Equitec Proprietary Markets’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9
Closed -$9K – 289
2021
Q2 		$9K Buy
+9
New +$9.79K ﹤0.01% 235
2020
Q4 		$2.58M Buy
1,977
+898
+83% +$981K 0.67% 20
2020
Q3 		$1.51M Buy
+1,079
New +$1.73M 1.15% 24
2020
Q1 		$1.12M Buy
+756
New +$3.62M 0.35% 27

Other funds holding SONM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Equitec Proprietary Markets's SONM Position: Q3 2021 in Review

Equitec Proprietary Markets sold out of DNA X Inc (SONM) in Q3 2021, closing a stake of 9 shares — an estimated $9K sold.

Equitec Proprietary Markets first reported a position in SONM in Q1 2020 and held it in 4 quarters. The position peaked at $2.58M in Q4 2020. 11 funds tracked by Wall St. Rank hold SONM as of Q3 2021.

  • Equitec Proprietary Markets reported no remaining DNA X Inc position as of Q3 2021 after selling out during the quarter.
  • Equitec Proprietary Markets sold 9 DNA X Inc shares in Q3 2021, an estimated $9K.
  • Equitec Proprietary Markets first reported a position in DNA X Inc in Q1 2020 and held it in 4 quarters.
  • Equitec Proprietary Markets's DNA X Inc position peaked at $2.58M in Q4 2020.
  • 11 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2021.

Based on Equitec Proprietary Markets's 13F filing for Q3 2021, filed 12 Oct 2021.